OBJECTIVES: The Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE)
program was initiated by the International Organization for the Study of Inflammatory Bowel …

Background The Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE)
initiative of the International Organization for the Study of Inflammatory Bowel Diseases …

Background and Aims Inflammatory bowel diseases (IBD), encompassing Crohn's disease
(CD) and ulcerative colitis (UC), are chronic and disabling disorders. Prospective disease …

A careful integration of the effectiveness and safety of the therapies for inflammatory bowel
disease, considering patients' disease risks, treatment complications and preferences, is …

Abstract Background and Aims: Many uncertainties remain regarding optimal therapies and
strategies for the treatment of inflammatory bowel disease. Setting research priorities …

Background With the introduction of novel therapies for inflammatory bowel diseases
(IBD),'treat‐to‐target'strategies are increasingly discussed to improve short‐and long‐term …

New targets in inflammatory bowel disease therapy: 2021 : Current Opinion in
Gastroenterology New targets in inflammatory bowel disease therapy: 2021 : Current …

Systematic approaches for assessing evidence and making recommendations (such as the
GRADE system) hold the promise of improving health outcomes. For diseases with multiple …

Short-and long-term treatment targets in inflammatory bowel diseases (IBDs) evolved during
the last decade, shifting from symptom control to endoscopic healing and patient-centered …

Outcomes for patients starting a new treatment for inflammatory bowel disease are
characterized by uncertainty of treatment response. Although it is natural to hope that new …